Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

…can you or someone else elaborate on why CW stated that losing some in the trial might actually make them stronger in the [Copaxone patent] appeals process?

It’s not that losing an argument in the District Court is beneficial per se, but rather that the Appellate Court could render a different ruling on any specfic argument, so you don’t know the ultimate outcome until the appeal is taken. (We saw this with the Appellate Court’s lifting of the Lovenox injunction.)